Evidence map›Paper›PMID 36335489›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2023

Interrogating the Human Diplome: Computational Methods, Emerging Applications, and Challenges.

Agnes P Chan, Yongwook Choi, Aditya Rangan, Guangfa Zhang, Avijit Podder, Michael Berens, Sunil Sharma, Patrick Pirrotte, Sara Byron, Dave Duggan and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Agnes P ChanThe Translational Genomics Research Institute (TGen), part of the City of Hope National Medical Center, Phoenix, AZ, USA.
Yongwook ChoiThe Translational Genomics Research Institute (TGen), part of the City of Hope National Medical Center, Phoenix, AZ, USA.
Aditya RanganCourant Institute of Mathematical Sciences at New York University, New York, NY, USA.
Guangfa ZhangThe Translational Genomics Research Institute (TGen), part of the City of Hope National Medical Center, Phoenix, AZ, USA.
Avijit PodderThe Translational Genomics Research Institute (TGen), part of the City of Hope National Medical Center, Phoenix, AZ, USA.
Michael BerensThe Translational Genomics Research Institute (TGen), part of the City of Hope National Medical Center, Phoenix, AZ, USA.
Sunil SharmaThe Translational Genomics Research Institute (TGen), part of the City of Hope National Medical Center, Phoenix, AZ, USA.
Patrick PirrotteThe Translational Genomics Research Institute (TGen), part of the City of Hope National Medical Center, Phoenix, AZ, USA.
Sara ByronThe Translational Genomics Research Institute (TGen), part of the City of Hope National Medical Center, Phoenix, AZ, USA.
Dave DugganThe Translational Genomics Research Institute (TGen), part of the City of Hope National Medical Center, Phoenix, AZ, USA.
Nicholas J SchorkThe Translational Genomics Research Institute (TGen), part of the City of Hope National Medical Center, Phoenix, AZ, USA. nschork@tgen.org.

Funding

Systems BiologyU19AG023122 · NIA · TRANSLATIONAL GENOMICS RESEARCH INST · PI NICHOLAS Joseph SCHORK · 2004 to 2026
$102.6M
Regulatory and Human Study Operations (RHSO) Core CU19AG065169 · NIA · UNIVERSITY OF ARIZONA · PI HUENTELMAN, MATT · 2021 to 2025
$59.8M
Participant Engagement UnitU2CCA252973 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Cindy Kay Blair · 2020 to 2026
$21.0M
Integrative Omics to enhance therapeutics development for healthy agingUH3AG064706 · NIA · TRANSLATIONAL GENOMICS RESEARCH INST · PI MILLER, RICHARD A, SCHORK, NICHOLAS JOSEPH · 2021 to 2024
$3.3M
Enhancing the efficacy of immunotherapy in DLBCL using rational combination approachesU01CA224153 · NCI · TUFTS UNIVERSITY BOSTON · PI LONDON, CHERYL A · 2017 to 2021
$3.1M
Novel Biomarkers and Genetics of Diabetic RetinopathyR01EY028606 · NEI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI DAS, ARUP · 2018 to 2022
$2.8M
Integrative Omics to enhance therapeutics development for healthy agingUH2AG064706 · NIA · TRANSLATIONAL GENOMICS RESEARCH INST · PI MILLER, RICHARD A, SCHORK, NICHOLAS JOSEPH · 2019 to 2020
$1.4M
NCI NIH HHS U01 CA224153NCI NIH HHS U2C CA252973NIA NIH HHS U19 AG023122NIA NIH HHS U19 AG065169NIA NIH HHS UH2 AG064706
6 · The paper itself

Abstract

Human DNA sequencing protocols have revolutionized human biology, biomedical science, and clinical practice, but still have very important limitations. One limitation is that most protocols do not separate or assemble (i.e., "phase") the nucleotide content of each of the maternally and paternally derived chromosomal homologs making up the 22 autosomal pairs and the chromosomal pair making up the pseudo-autosomal region of the sex chromosomes. This has led to a dearth of studies and a consequent underappreciation of many phenomena of fundamental importance to basic and clinical genomic science. We discuss a few protocols for obtaining phase information as well as their limitations, including those that could be used in tumor phasing settings. We then describe a number of biological and clinical phenomena that require phase information. These include phenomena that require precise knowledge of the nucleotide sequence in a chromosomal segment from germline or somatic cells, such as DNA binding events, and insight into unique cis vs. trans-acting functionally impactful variant combinations-for example, variants implicated in a phenotype governed by compound heterozygosity. In addition, we also comment on the need for reliable and consensus-based diploid-context computational workflows for variant identification as well as the need for laboratory-based functional verification strategies for validating cis vs. trans effects of variant combinations. We also briefly describe available resources, example studies, as well as areas of further research, and ultimately argue that the science behind the study of human diploidy, referred to as "diplomics," which will be enabled by nucleotide-level resolution of phased genomes, is a logical next step in the analysis of human genome biology.

Indexed as

DiploidyGenome, HumanBase SequenceComputational BiologyHaplotypesHigh-Throughput Nucleotide SequencingHumansNucleotidesSequence Analysis, DNANucleotidesCancer and DNA/RNA bindingEpistasisFunctional predictionGenetic variationGenomicsHaplotypingPhasing

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.